WO2020140014A1 - Système et procédé de vérification de médicament - Google Patents

Système et procédé de vérification de médicament Download PDF

Info

Publication number
WO2020140014A1
WO2020140014A1 PCT/US2019/068702 US2019068702W WO2020140014A1 WO 2020140014 A1 WO2020140014 A1 WO 2020140014A1 US 2019068702 W US2019068702 W US 2019068702W WO 2020140014 A1 WO2020140014 A1 WO 2020140014A1
Authority
WO
WIPO (PCT)
Prior art keywords
medication
reader device
information
code
biometric
Prior art date
Application number
PCT/US2019/068702
Other languages
English (en)
Inventor
John Woodyear
Original Assignee
John Woodyear
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/233,173 external-priority patent/US10896752B2/en
Application filed by John Woodyear filed Critical John Woodyear
Priority to CN201980093154.0A priority Critical patent/CN113519030A/zh
Priority to EP19906542.6A priority patent/EP3903233A4/fr
Priority to JP2021538113A priority patent/JP2022516504A/ja
Publication of WO2020140014A1 publication Critical patent/WO2020140014A1/fr
Priority to US17/351,627 priority patent/US11842804B2/en
Priority to ZA2021/05162A priority patent/ZA202105162B/en
Priority to US18/535,799 priority patent/US20240112780A1/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers

Definitions

  • Exemplary embodiments of the present invention relate generally to systems and methods for verifying legitimate possession of a prescription medication.
  • the present invention helps alleviate the abuse of prescription drugs by providing a system and method for verifying individual pills by scanning a code printed on said pills, retrieving associated information about the person legally prescribed the pills in question (e.g., their name), and comparing that information to information about the person actually possessing the pill (e.g., against their government issued ID).
  • Drugs particularly medicines, have the power to treat illnesses and prevent disease when used properly. Drugs also have the power to be abused, cause addiction, and damage the human body when used improperly. In light of this, governments have implemented methods to control the distribution and use of drugs most likely to be abused.
  • controls appear in the form of prescription requirements wherein a person must be prescribed a set amount of the drug by a licensed medical professional in order to legally possess and use said drug.
  • control over prescribed pills is lost once they pass over the dispensary’s counter.
  • drugs most likely to be abused are often further classified and regulated. Typically, a certain number of these drugs are outright banned from being possessed or used (e.g., heroin, cocaine) due to their dangerous nature and relatively low utility in a medical application.
  • Another select group of drugs are permitted to be possessed and used by prescription, but face additional regulations and controls. These often include, without limitation, narcotics, benzodiazepines, sedatives, hypnotics, and central nervous system stimulants.
  • system and method may be used by law enforcement officials to quickly, accurately, and securely identify if a person legally possesses a controlled substance or other prescription medication.
  • the present invention provides such a system and method for the verification of medication that is capable of individually verifying prescription drugs.
  • the present invention comprises a coding system whereby a medication has been marked with a code, such as a bar code or a quick response (QR) code.
  • a code such as a bar code or a quick response (QR) code.
  • the code comprises an embedded serial number that is displayed when the code is read or interpreted by a reader device.
  • the serial number includes a lot or batch number and may include further information such as the identity of the manufacturer. In this way, all medications of a lot or batch may be marked with the same code, which simplifies the marking process such that a unique code need not be printed on each medication.
  • the serial number may be linked to a patient at the time a prescription is filed and be stored in a prescription database.
  • the present invention further comprises a patient identification system whereby a software application (an“app”) or website on a mobile device is designed to read and interpret the code.
  • a software application an“app” or website on a mobile device is designed to read and interpret the code.
  • the code may be a QR code that is read by the camera on a smart phone and the information is transmitted to the app for processing. A comparison may then be made to a code printed on the prescription bottle to determine whether a match is made and thus that the pills in the bottle are legitimately possessed by the person.
  • a prescription bottle is not present (i.e., the person possesses loose pills), or if the code on the pill does not match the prescription bottle, the code on the pills may be scanned using the app and the person’s name may be entered.
  • the app may then relay this information to a first server, which may query the appropriate prescription database.
  • the prescription database may return the name of the person legally prescribed the pills in question. This name may be returned to the device, via the first server, and the device may determine if there is a match between the entered name (the person actually possessing the pills in question) and the returned name (the person legally prescribed the pills in question).
  • the name of the person legally prescribed the pills may be returned and the user may determine whether the returned name matches the name of the person actually possessing the pills.
  • facial recognition technology may be used to identify the person in possession of the pills in question.
  • the prescription database may comprise facial data for the person legally prescribed the medication.
  • the reader device may be used to scan the code on the medication as well as the face of the person in possession of the medication. This information may be relayed to the appropriate prescription database where a check may be performed and a notification of whether the scanned face is a match or not a match for the person who was legally prescribed the pills may be returned for display on the reader device.
  • the message may be color coded such as green for match and red for no match.
  • biometric information may be utilized, such as but not limited to, fingerprints, finger, hand, or other body part geometry, odor, vein, blood samples, hair, or tissue samples, partial or whole DNA sequences, ear shape, gait, signature, retina, iris, or other eye information, voice patterns or other voice information, some combination thereof, or the like.
  • this system and method may be used in the context of law enforcement to verify the legality of the person’s possession of the prescription medication.
  • this application is merely exemplary and other applications are contemplated including quality control, preventing drug interactions, and any other application where verification of prescription medication is desirable.
  • exemplary users of the present invention include, but are not limited to, law enforcement officials, medical professionals, manufacturers, and anyone else involved in the care, handling, and regulation of prescription drugs.
  • Figure 1 illustrates an exemplary embodiment of a system in accordance with the present invention
  • Figure 2 is a top view of an exemplary pill for use with the system of figure 1 ;
  • Figure 3 is a top view of another exemplary pill for use with the system of figure 1 ;
  • Figure 4 is a perspective view of an exemplary pill container for use with the system of figure 1 ;
  • Figure 5 illustrates a detailed view of the system of figure 1 ;
  • Figure 6 is an exemplary method in accordance with the present invention.
  • Figure 7 is another exemplary method
  • Figure 8 is another exemplary method
  • Figure 9 is another exemplary method
  • Figure 10 is another exemplary method in accordance with the present invention.
  • Figure 11 is another exemplary method in accordance with the present invention.
  • FIG. 1 through Figure 5 illustrates an exemplary system in accordance with the present invention.
  • a medication 12 such as a pill, tablet, capsule, or the like is marked with a code 24.
  • the code 24 may be a one-dimensional code such as a UPC, EAN, Code 39, Code 128, ITF, Code 93, Codabar, GS1 Databar, MSI Plessey or the like.
  • the code 24 may be a two-dimensional code such as a quick response (hereinafter“QR”) code, datamatrix code, PDS417, Aztec, or the like.
  • Figure 2 and figure 3 illustrate detailed views of exemplary medications 12 marked with exemplary codes 24.
  • Two-dimensional codes are well known in the art. A brief description is provided herein for completeness but is not intended to be limiting. Two dimensional codes are optically machine-readable labels containing encoded information about the item to which it is attached.
  • the QR code for example without limitation, consists of three alignment targets and a series of black modules (typically square markings) arranged in a square grid on a white background, and are capable of being read by an imaging device such as a camera. Some of the black modules are directed to formatting information and the rest are generally directed to the underlying data, which can be any kind of information.
  • the image is often processed using Reed-Solomon error correction until the image can be appropriately interpreted.
  • the required data is then extracted from patterns that are present in both horizontal and vertical components of the image and is generally interpreted in numeric, alphanumeric, byte/binary, and Kanji forms, though other forms are possible.
  • the code 24 comprises encoded data for translating at least a portion of the code 24 into a serial number.
  • the serial may be 10-12 digits, though any number of digits is contemplated, and may comprise letters, numbers, other symbols, or some combination thereof.
  • the code 24 may be a series of non- encoded letters and/or numbers (i.e., a list of printed letters and/or numbers) of any number of digits.
  • the code 24 is the serial number.
  • the code 24 or the translated, embedded serial number may comprise a lot or batch number.
  • the code 24 may be translated into the serial number, the lot, and batch number.
  • the embedded serial number may be the lot and batch number.
  • the code 24 may additionally comprise other embedded information such as, but not limited to, the manufacture date, the manufacture’s name or identification information, the content of the medication 12, or any other information about the medication 12 and its manufacture.
  • the serial number may be determined by any known or future standardized system.
  • the serial number may comprise any numbered of coded or uncoded portions that are intended to convey information about the medication 12.
  • the code 24 may be placed on the medication 12 during manufacture by any known method. Alternatively, the code 24 may be placed on the medication 12 at a later stage. A number of methods and systems for imprinting medication 12 with information are known in the arts. In exemplary embodiments of the present invention, a system and method is used that prints the code 24 with a sufficient resolution that it may be read by a relatively low-resolution camera, such as but not limited to, one on a smart phone or other mobile device.
  • the ink used to print the code 24 may be any ink that is safe for human consumption, such as but not limited to, those approved by the Food and Drug Administration (FDA).
  • the surface of the medication 12 may comprise a coating or surface texture amenable to the adherence of the ink.
  • the medication 12 having the code 24 printed thereon may then be placed in a storage container 14.
  • the storage container 14 may be any container for storing medication 12.
  • the storage container 14 may be a prescription bottle.
  • only medication 12 from the same lot or batch, such that it contains the same code 24, may be placed in a single storage container 14.
  • medication 12 of a“split lot” or a“split batch” would require separate storage containers 14. This simplifies the printing process, such that a unique code need not be marked on each medication 12.
  • Figure 4 illustrates a detailed view of the storage container 14.
  • the storage container 14 may further comprise a label having patient and prescription information 28.
  • the storage container 14 further comprises a corresponding code 26.
  • the corresponding code 26, like the code 24, may be a one-dimensional code, a two-dimensional code, or the like.
  • the code 24 matches, is identical to, or is otherwise associated with the corresponding code 26. It is notable that the corresponding code 26 is optional and may not be required for exemplary embodiments of the present invention.
  • the code 24 and the corresponding code 26 may be configured to be read and interpreted by a reader device 16.
  • the reader device 16 may be a mobile device such as a smart phone, camera, tablet, laptop or the like.
  • the reader device 16 may additionally be a dedicated scanning device or attachment for a mobile device, such as a code reading device, a scanner, terminal or any other fixed or mobile device or attachment configured to read and interpret one and two dimensional codes 24.
  • the reader device 16 may be configured to read and interpret the code 24 and the corresponding code 26, input and receive other information, display the encoded information, and input, receive, and display match information.
  • the encoded information is the serial number comprising at least a lot or batch number and the match information is a message displaying“MATCH” or“NO MATCH” or similar.
  • the system and method described herein may be used by law enforcement officials to determine whether a person carrying medication 12 is legally permitted to possess or use said medication 12. This information may be used to make decisions regarding whether to pursue a further investigation, continue detention of the person, perform a search of the person, their dwelling, vehicle, personal belongings, and the like, or to make an arrest.
  • other applications are contemplated including quality control, preventing drug interactions, and any other application where verification of prescription medication is desirable. Any purpose or application is contemplated.
  • the reader device 16 may be in communication with a first server 18 via a communications network 20, such as the internet.
  • the first server 18 may likewise be in communication with a prescription database 22 via the communications network 20.
  • the prescription database 22 may be part of a state or federally controlled prescription database program, such as but not limited to the PDMP.
  • the prescription database 22 may be a single database or comprise multiple databases that are linked and may be queried together. This may include, but is not limited to, a national network of state prescription databases or a national prescription database.
  • the first server 18 may receive the serial number and other information from the reader device 16 and send a query to the prescription database 22 to compare the serial number and other information against patient registration information.
  • the query may be an automated request for information from the prescription database 22.
  • the first server 18 may also determine which prescription database 22 to query.
  • only the prescription database 22 for the state in which the user is located or employed in may be queried.
  • the prescription database 22 for the state in which the user is located or employed to work in and the adjoining states may be queried.
  • the query of any number of prescription databases 22 for any number of states in any combination is contemplated.
  • the prescription database 22 to be queried may be pre-determined and thus the first server 18 may serve as a relay in communications between the reader device 16 and the prescription database 22.
  • the prescription database 22 may perform an automated query and determine patient information associated with the serial number.
  • the patient information may include, but is not limited to, the patient’s name, address, physical description, prescription information, photograph, and the like. The patient information may then be transmitted back to the first server 18 and back to the reader device 16.
  • the reader device 16 may also be configured to receive and transmit other input including, but not limited to, the person’s name, state where prescription was filled, particular database to be queried, date of birth, and other identifying information. This information may likewise be transmitted via the communications network 20 to the first server 18. The first server 18 may only check to see if the patient information matches the name information transmitted by the reader device 16. The first server 18 may then transmit the match information back to the reader device 16 to be displayed.
  • the name and the serial number information may be transmitted to the prescription database 22 where the prescription database 22 determines whether the information is a match and relays back the match information.
  • the prescription database 22 may transmit corresponding patient information to the first server 18 and the information may be relayed to the reader device 16 and the reader device 16 may determine if there is a match and display the match information.
  • the reader device 16 may be configured to display match information to the user including whether or not a match was determined.
  • only the serial number may be transmitted to the prescription database 22 and the prescription database 22 may return the patient information associated with the serial number to the reader device 16 such that the user may make a match determination.
  • the reader device 16 may read the code 24 and the corresponding code 26 and display match information.
  • the reader device 16 may read the code 24 and the corresponding code 26 and display the serial numbers for comparison.
  • Figure 6 illustrates an exemplary method in accordance with the present invention.
  • the code 24 may be placed on the medication 12.
  • the code 24 may be placed by printing or any other known method for marking the medication 12. The printing may be accomplished at the manufacturing facility, at the packaging facility, at the dispensing pharmacy, at a separate printing facility, or any other place prior to dispensing the medication 12 to the person.
  • the corresponding code 26 is placed on the storage container 14.
  • the corresponding code 26 may be placed by printing or any other known method for marking the storage container 14.
  • the code 24 and the corresponding code 26 may be associated with patient information and linked thereto and stored in the prescription database 22.
  • this information may be gathered and linked to or otherwise associated with the patient when the prescription is ordered or filled and may be associated and caused to be placed in the prescription database 22 by the doctor, pharmacist, or other medical professional.
  • the patient information may be manually entered into a computer system. For example, without limitation, this may be done for new patients or when updating patient information.
  • the patient information may be automatically entered from information already known by the doctors, pharmacist, or other medical professional. For example, without limitation, this may be done for existing patients by automatically populating a form or uploading information from the medical professional’s files.
  • the steps listed are merely exemplary and may be performed in any order. Additionally, various steps may be repeated or omitted.
  • Figure 7 illustrates an exemplary method for verifying proper possession of medication.
  • the code 24 on the medication 12 may be scanned using the reader device 16.
  • the information from the code 24 may be transmitted by the reader device 16 to the first server 18 via the communications network 20.
  • the first server 18 may determine which prescription database 22 to query and in step 216 the appropriate prescription database 22 is queried.
  • the prescription database 22 is the state-controlled PDMP, and thus the first server 18 may determine which state’s prescription database 22 to query. This may be done by the input from the user and the transmission of additional information from the reader device 16 to the first server 18.
  • This information may include a state selected by the user according to the persons’ license information, stated information about the persons’ residence, location of prescribing physician, or location of dispensing pharmacy.
  • the first server 18 may make an assumption on which state databases 22 are to be queried including by first querying the database of the state where the user is located and if no matching information is found, by subsequently querying databases 22 at an increasing geographic distance until matching information is found or all databases 22 have been queried.
  • step 218 the corresponding information may be retrieved from the prescription database 22 and transmitted to the first server 18.
  • the first server 18 may then transmit the information to the reader device 16.
  • step 220 the transmission of information may be accomplished by the communications network 20.
  • FIG 8 illustrates another exemplary method.
  • the reader device 16 is used to scan the code 24 on the medication 12.
  • the persons’ name may be entered into the reader device 16.
  • the name and serial number from the code 24 may be transmitted to the first server 18.
  • the first server 18 may determine which prescription database 22 to query. Step 316 may be accomplished by any of the several methods previously discussed and in step 318, the appropriate prescription database 22 may be queried.
  • the prescription database 22 may determine if there is a match between the name and the code information. The match information may then be transmitted to the first server 18 in step 322.
  • the first server 18 may transmit the match information to the reader device 16. Alternatively, the information may be transmitted from the database and the match determination may be made by the first server 18 or by the user of the reader device 16.
  • Figure 9 illustrates another method whereby in step 410 the code 24 on the medication 12 may be scanned using the reader device 16.
  • the corresponding code 26 on the storage container 14 may likewise be scanned by the reader device 16.
  • it may be determined if there is a match by any of the several methods previously discussed. If there is a match, as noted in step 416 the investigation may be ended. If there is no match, the same procedure may be followed for steps 418, 420, 422, 424, 426, 428, and 430, which generally corresponds to steps 312, 314, 316, 318,
  • step 418 is optional and may be skipped and a procedure similar to steps 210, 212, 214, 216, 218, and 220 of figure 7, respectively, may instead be followed.
  • Figure 10 illustrates another exemplary method whereby facial recognition technology is utilized.
  • the code 24 on the medication 12 may be scanned using the reader device 16 at step 510.
  • the code 26 on the storage container 14 may be scanned. Regardless, the scan of the code 24 or code 26 may permit the reader device 16 to extract an embedded serial number.
  • an image of the face of the person in possession of the medication 12 may be taken. The image may be captured using the reader device 16.
  • the reader device 16 may comprise one or more cameras capable of photographing an individual’s face.
  • initial facial recognition processing such as but not limiting to, extracting facial characteristic data from the image of the captured face (e.g., eye spacing distance, distance from forehead to chin, etc.) may be performed at the reader device 16 such that the extracted facial characteristic data is transmitted.
  • initial facial recognition processing may be performed at the prescription database 22 and simply the image data may be transmitted.
  • the initial facial recognition processing may be performed at the first server 18.
  • the extracted serial number as well as the facial characteristic data or the image data may be transmitted to the first server 18.
  • the first server 18 may determine which prescription database 22 to query at step 516.
  • One or more entries on one or more of the prescription databases 22 may comprise facial characteristic data for persons prescribed medications 12.
  • the facial characteristic data may be extracted from an image of the person prescribed the medication. Such images may be captured at the dispensing, prescribing, or the like of such medications 12.
  • the image processing required to extract the facial characteristic data may be performed where the image was captured, at the first server 18, or at the prescription database 22.
  • the appropriate prescription database 22 may be queried.
  • the query may return the facial characteristic data associated with the queried serial number.
  • a match between the facial characteristic data of the person possessing the medication and the retrieved facial characteristic data associated with the queried serial number may be determined.
  • the match information may be transmitted to the first server 18.
  • the match information may indicate a match or no match between the facial characteristic data of the person possessing the medication and the retrieved facial characteristic data associated with the queried serial number.
  • the match information may be transmitted to the reader device 16 for display.
  • the reader device 16 may be configured to simply display whether or not a match was received. For example, without limitation, the words“match” or“no match” may be displayed.
  • the results may be color coded for ease of review, such as green for match and red for no match.
  • the facial characteristic data for the person prescribed the medication may be transmitted to the reader device 16 which performs the match analysis. If no facial characteristic data is available for the individual, other methods and systems may be utilized such as but not limited to, those shown and described herein.
  • the components described herein, such as but not limited to, the reader device 16, the first server 18, and the prescription database 22 may each comprise one or more electronic storage devices which comprise executable software instructions and one or more processors for executing said executable software instructions.
  • the execution of said executable software instructions may configure the respective device (i.e., the reader device 16, the first server 18, or the prescription database 22) to perform one or more functions described herein.
  • Figure 11 illustrates another exemplary embodiment where other types of biometric information may be utilized, individually or in combination with those other types of biometric or other information and embodiments shown and/or described herein.
  • biometric information may be utilized with the systems and method shown and/or described with respect to figure 10, with similar items being numbered similarly but increased by 100 (i.e., 510 to 610), though such methods may be utilized with any of the additional figures and/or embodiments provided herein.
  • biometric information may include, for example without limitation, fingerprints, finger, hand, or other body part geometry, odor, vein, blood samples, hair, or tissue samples, partial or whole DNA sequences, ear shape, gait, signature, retina, iris, or other eye information, voice patterns or other voice information, some combination thereof, or the like.
  • any embodiment of the present invention may include any of the optional or preferred features of the other embodiments of the present invention.
  • the exemplary embodiments herein disclosed are not intended to be exhaustive or to unnecessarily limit the scope of the invention.
  • the exemplary embodiments were chosen and described in order to explain the principles of the present invention so that others skilled in the art may practice the invention. Having shown and described exemplary embodiments of the present invention, those skilled in the art will realize that many variations and modifications may be made to the described invention. Many of those variations and modifications will provide the same result and fall within the spirit of the claimed invention. It is the intention, therefore, to limit the invention only as indicated by the scope of the claims.
  • Each electronic device may comprise one or more processors, electronic storage devices, executable software instructions, and the like configured to perform the operations described herein.
  • the electronic devices may be general purpose computers or specialized computing device.
  • the electronic devices may be personal computers, smartphone, tablets, databases, servers, or the like.
  • the electronic connections and transmissions described herein may be accomplished by wired or wireless means.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

L'invention concerne des systèmes et des procédés pour vérifier la possession correcte d'un médicament. Un dispositif de lecture balaye un code imprimé sur le médicament pour extraire un numéro de série intégré. Le dispositif de lecture capture des informations biométriques d'une personne en possession du médicament. Un premier serveur interroge une base de données de prescription qui récupère des données de caractéristiques biométriques associées au numéro de série intégré. Une détermination est effectuée si les données de caractéristiques biométriques récupérées correspondent à des données de caractéristique biométrique. Les informations de correspondance sont affichées sur le dispositif de lecture.
PCT/US2019/068702 2016-02-11 2019-12-27 Système et procédé de vérification de médicament WO2020140014A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN201980093154.0A CN113519030A (zh) 2018-12-27 2019-12-27 用于药物验证的系统和方法
EP19906542.6A EP3903233A4 (fr) 2018-12-27 2019-12-27 Système et procédé de vérification de médicament
JP2021538113A JP2022516504A (ja) 2018-12-27 2019-12-27 薬の検証のためのシステム及び方法
US17/351,627 US11842804B2 (en) 2018-12-27 2021-06-18 System and method for the verification of medication
ZA2021/05162A ZA202105162B (en) 2018-12-27 2021-07-21 System and method for the verification of medication
US18/535,799 US20240112780A1 (en) 2016-02-11 2023-12-11 System and method for the verification of medication

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/233,173 US10896752B2 (en) 2016-02-11 2018-12-27 System and method for the verification of medication
US16/233,173 2018-12-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US16/233,173 Continuation-In-Part US10896752B2 (en) 2016-02-11 2018-12-27 System and method for the verification of medication

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/351,627 Continuation US11842804B2 (en) 2016-02-11 2021-06-18 System and method for the verification of medication

Publications (1)

Publication Number Publication Date
WO2020140014A1 true WO2020140014A1 (fr) 2020-07-02

Family

ID=71127165

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2019/068702 WO2020140014A1 (fr) 2016-02-11 2019-12-27 Système et procédé de vérification de médicament

Country Status (5)

Country Link
EP (1) EP3903233A4 (fr)
JP (1) JP2022516504A (fr)
CN (1) CN113519030A (fr)
WO (1) WO2020140014A1 (fr)
ZA (1) ZA202105162B (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2327283A1 (fr) * 1998-04-15 1999-10-21 James E. Beecham Procede, systeme et appareil d'identification biometrique
US20080120698A1 (en) * 2006-11-22 2008-05-22 Alexander Ramia Systems and methods for authenticating a device
US20110015945A1 (en) * 2009-07-17 2011-01-20 Hand Held Products, Inc. Biometric medication administration system and method
US20110100863A1 (en) * 2004-10-01 2011-05-05 Edge Medical Properties, Llc Dual dispensing tablet container
US20120185267A1 (en) * 2010-01-22 2012-07-19 Deka Products Limited Partnership System, Method, and Apparatus for Electronic Patient Care
WO2013139221A1 (fr) * 2012-03-19 2013-09-26 腾讯科技（深圳）有限公司 Procédé, dispositif et système d'authentification basés sur des caractéristiques biologiques
US20140089011A1 (en) * 2011-12-09 2014-03-27 Xerox Business Services, Llc Medication Management System
US20170235916A1 (en) 2016-02-11 2017-08-17 John Woodyear System and method for the verification of medication
US20190139639A1 (en) * 2016-02-11 2019-05-09 John Woodyear System and method for the verification of medication

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1749273A4 (fr) * 2004-05-18 2011-12-28 Silverbrook Res Pty Ltd Authentification d'un objet au moyen d'une signature codee dans un certain nombre de parties de donnees
US8655796B2 (en) * 2011-06-17 2014-02-18 Sanjay Udani Methods and systems for recording verifiable documentation
US9290010B2 (en) * 2011-10-06 2016-03-22 AI Cure Technologies, Inc. Method and apparatus for fractal identification
US9576355B2 (en) * 2014-01-31 2017-02-21 Catamaran Corporation System and method of monitoring and confirming medication dosage
US20160314276A1 (en) * 2015-04-24 2016-10-27 Hand Held Products, Inc. Medication management system

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2327283A1 (fr) * 1998-04-15 1999-10-21 James E. Beecham Procede, systeme et appareil d'identification biometrique
US20110100863A1 (en) * 2004-10-01 2011-05-05 Edge Medical Properties, Llc Dual dispensing tablet container
US20080120698A1 (en) * 2006-11-22 2008-05-22 Alexander Ramia Systems and methods for authenticating a device
US20110015945A1 (en) * 2009-07-17 2011-01-20 Hand Held Products, Inc. Biometric medication administration system and method
US20120185267A1 (en) * 2010-01-22 2012-07-19 Deka Products Limited Partnership System, Method, and Apparatus for Electronic Patient Care
US20140089011A1 (en) * 2011-12-09 2014-03-27 Xerox Business Services, Llc Medication Management System
WO2013139221A1 (fr) * 2012-03-19 2013-09-26 腾讯科技（深圳）有限公司 Procédé, dispositif et système d'authentification basés sur des caractéristiques biologiques
US20170235916A1 (en) 2016-02-11 2017-08-17 John Woodyear System and method for the verification of medication
US20190139639A1 (en) * 2016-02-11 2019-05-09 John Woodyear System and method for the verification of medication

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3903233A4

Also Published As

Publication number Publication date
CN113519030A (zh) 2021-10-19
EP3903233A4 (fr) 2022-08-31
ZA202105162B (en) 2023-05-31
EP3903233A1 (fr) 2021-11-03
JP2022516504A (ja) 2022-02-28

Similar Documents

Publication Publication Date Title
US20200350048A1 (en) System and method for the verification of medication
US10897461B2 (en) Pharmacy database access methods and systems
US20160253476A1 (en) System and method for collecting and authenticating medication consumption
CN109616173B (zh) 药品管理方法、装置、计算机设备及存储介质
US20190206174A1 (en) Automated dispensing machine with improved security
US20160246928A1 (en) Medication reconciliation system and method
US12009082B2 (en) System and method for the verification of medication
KR20170033864A (ko) 의료 전달 디바이스의 활성화를 감지하기 위한 시스템 및 방법
US20110015945A1 (en) Biometric medication administration system and method
US20140324216A1 (en) Method, system and apparatus for managing medication delivery
KR101744123B1 (ko) 의약품 식별 장치 및 그 방법
AU2020101208A4 (en) System And Method For Vaccine Administration Verification
US20190272908A1 (en) System and method for detecting pharmaceutical counterfeit and fraudulent prescription
US20160180131A1 (en) Method for providing qr code-based service for checking for occurrence of cocktail effect of drugs using smart device
US11842804B2 (en) System and method for the verification of medication
JP2016126361A (ja) 薬剤情報管理システム
US20210295968A1 (en) Systems, devices and methods for securing, storing and accessing pet and veterinary information
US20240112780A1 (en) System and method for the verification of medication
US20120053956A1 (en) System and method for configuring a multi-function device
WO2020140014A1 (fr) Système et procédé de vérification de médicament
US20100063624A1 (en) Monitoring Method And System
OA20509A (en) System and method for the verification of medication
CA2327283A1 (fr) Procede, systeme et appareil d'identification biometrique
NL2012301C2 (en) Digital care communication and information system.
WO2019147374A1 (fr) Système et procédé d'authentification d'objets au moyen de contrôles d'accès autorisés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19906542

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021538113

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019906542

Country of ref document: EP

Effective date: 20210727